Harley, Brendan A.
- University of Illinois at Urbana-Champaign (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,178
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.2M
Full award amounts, FY2023
Award Records
7
Records listing this PI
Award-Linked Rank
#3,178
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Harley, Brendan A. as a PI. Multi-PI records show the full award amount for context.
- 2R01DK099528-06A1R01Contact PIGradient biomaterials to investigate niche regulation of hematopoiesis$601.7Kaward amount
- 5R01CA256481-03R01Contact PIPerivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma$490.5Kaward amount
- 5R01DE030491-03R01Contact PIMineralized collagen composite to accelerate craniofacial bone regeneration$432.3Kaward amount
- 5R01AR077858-03R01Contact PIStratified and mechanically-tough biomaterial implant to improve tendon-to-bone enthesis regeneration$387Kaward amount
- 3R01CA256481-03S3R01Contact PISynthetic manipulation of engineered perivascular niches$164.2Kaward amount
- 3R01CA256481-03S1R01Contact PIPerivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma$88.7Kaward amount
- 3R01CA256481-03S2R01Contact PIPerivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma$44.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Harley, Brendan A. as a PI.
FY2023 award administered by University of Illinois at Urbana-Champaign (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardUniversity of Illinois at Urbana-Champaign
- 2014$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2016$2M Cumulative Funding
- 2016Entered Top 50% NationallyRanked #7687
- 2016R01 Grant Holder
- 2019$5M Cumulative Funding
- 2021Entered Top 25% NationallyRanked #4033
- 2023$10M Cumulative Funding